Table 3 Comparison of the contents of pharmacist interventions performed prior to mixing injectable anticancer agents before and after protocol modification
Intervention | Number of interventions (%) | |
|---|---|---|
Before modification | After modification | |
Patients’ infection-related condition | ||
Fever (≥ 37.5 °C) | 1 (0.7) | 8 (5.0) |
Elevated CRP or WBC | 2 (1.4) | 8 (5.0) |
Myelosupression | 116 (82.3) | 125 (78.6) |
Renal dysfunction | 10 (7.1) | 4 (2.5) |
Hepatic dysfunction | 9 (6.4) | 8 (5.0) |
Electrolytic imbalance | 3 (2.1) | 2 (1.3) |
Anemia | 0 | 3 (2.0) |
Peripheral neuropathy | 0 | 1 (0.6) |
Total | 141 | 159 |